Laxman Pai, Opalesque Asia: Chicago-based ARCH Venture Partners announced two new venture capital funds to invest in early-stage biotech companies with a combined total of $1.46 billion. They are ARCH Venture Fund X and ARCH Venture Fund X Overage.
ARCH formed in 1986 and made early investments in b...